MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

Unlike vaccines, Cidara’s products do not rely on the immune system. Credit: Andy Dean Photography via Shutterstock.com. MSD has agreed to acquire Cidara Therapeutics in a $9.2bn deal, adding a new ...

Enlicitide significantly reduces LDL-C in patients with high cardiovascular risk MSD has announced positive results from its phase 3 CORALreef Lipids trial, showing that enlicitide decanoate, an ...

Point and Blue Owl Capital have completed a $390 million securitization of home equity investment assets, marking the largest bond issuance in the history of the HEI space. This transaction reflects ...

RIYADH, Saudi Arabia: Lifera, a PIF Company, announces the signing of a non-binding Memorandum of Understanding (MOU) with MSD (also known as Merck & Co., Inc., Rahway, N.J., USA in the U.S. and ...

Merck & Co (MSD) has broken ground on its new pharmaceutical manufacturing Centre of Excellence in Virginia, US, amid looming tariff threats from the Trump administration. The $3bn site, which is ...

Adam Piekarski decided to go it alone after more than a decade at BDT & MSD Partners. He’s backing up that bet with a historic unveiling. Derby Lane Partners has amassed $1.8 billion in commitments ...

ST. LOUIS – From a hospital to housing complexes, some of our area’s largest institutions are behind on their utility bills. Thousands of account holders owe more than $100 million owed to the ...

MSD (Merck & Co., Inc.) will vacate its laboratories at the Francis Crick Institute in London by end‑2025 as it winds down discovery research in the UK. The move follows the decision to scrap a ...

Citing limited benefit and existing recordkeeping requirements, OSHA ends its rulemaking effort to add a musculoskeletal disorders column to the OSHA 300 Log. OSHA has officially withdrawn its ...

The National Safety Council announced last week that its MSD Solutions Pilot Grant programs have shown practical applications and measurable progress toward reducing musculoskeletal disorders (MSDs), ...